Huriamin HB-C Injection

Adult dosage

The total amino acid dosage should be administered intravenously with a maximum dosage of 1-1.5 g per kg of body weight per day. The infusion rate should aim for a concentration of approximately 10 g of total amino acids over 60 minutes, with a principle to administer 30-40 drops per minute.

Children's dosage

In children, the dosage and infusion rate should be adjusted.

This medication must only be used according to a doctor's instructions. It should not be administered to patients with hepatic coma or at risk of hepatic coma, severe renal impairment, problems with nitrogen metabolism, patients with catabolic heart failure or pulmonary edema, and to those whose urine output is minimal or absent. Additionally, if sodium or chloride ions are present, it should not be administered to patients with hypernatremia, hyperchloremia, or alkaline disorders. If magnesium ions are included, it should be avoided in patients with complete heart block or severe myasthenia. Patients with hypersensitivity to amino acids contained in this medication, those with hyperkalemia, and patients with a history of myocardial infarction should not receive it. Patients with severe acidosis, congestive heart failure, edema due to sodium retention, and liver or kidney disorders should use this medication with caution. This drug contains sodium bisulfite, which can trigger allergic reactions or asthma attacks; therefore, asthmatic patients should be particularly careful. During use, various adverse reactions such as skin rash, nausea, vomiting, palpitations, and elevated blood pressure may occasionally occur, so symptoms should be immediately reported to medical personnel. Rapid large volume administration may lead to acidosis, and severe symptoms such as chills, fever, headache, and dyspnea may rarely occur. When administering this drug, careful monitoring of electrolyte balance is required; especially in patients with impaired kidney or liver function, it should be administered cautiously to prevent fluid overload. Diabetic patients should regularly check their blood sugar levels, and since ketosis may occur when only amino acid solutions are administered, it is advisable to also provide carbohydrates. Regular tests for blood sugar, electrolytes, and liver and kidney function should be performed to closely monitor the condition. When combining with other medications, there may be interactions, especially when used with tetracyclines or calcium salts. Safety has not been established in pregnant women, so it should only be administered when the therapeutic benefit outweighs the risk. When administering to children, be mindful that liver function may be immature, so keep the concentration low and check blood ammonia levels frequently. In the elderly, due to decreased physiological function, administration should be done slowly and dosages adjusted. When administering, pay attention to electrolyte content and infusion speed; rapid infusion may cause chills or vomiting, so administer slowly. Preparation and management of intravenous fluids should be done in a sterile manner, and before administration, the solution should be checked for clarity and abnormalities should prevent its use.

Serious side effects

• Rash
• difficulty breathing
• respiratory arrest
• asthma attack

Mild side effects

• Nausea
• vomiting
• chest discomfort
• palpitations
• rapid heartbeat (tachycardia)
• elevated blood pressure
• chills
• fever
• headache
• shock

This medication should be stored in a sealed container to prevent air or moisture ingress. It is also important to store it in a place away from direct sunlight at normal room temperature, avoiding extremely hot or cold conditions.

Appearance

This medication is a transparent solution that is colorless to slightly yellow, contained in a polypropylene aqueous injection vial.

Package unit

100mL/pack